Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.01.2023 | Case report

Carboplatin/paclitaxel

Lack of efficacy: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Schott S, et al. POTENTIAL APPROACH TO OVERCOME CHECKPOINT INHIBITOR RESISTANCE IN A LONG-TERM SURVIVOR PATIENT WITH RECURRENT ENDOMETRIAL CARCINOMA. International Journal of Gynecological Cancer 32 (Suppl. 2): A159, Oct 2022. Available from: URL: http://doi.org/10.1136/ijgc-2022-ESGO.339 [abstract] Schott S, et al. POTENTIAL APPROACH TO OVERCOME CHECKPOINT INHIBITOR RESISTANCE IN A LONG-TERM SURVIVOR PATIENT WITH RECURRENT ENDOMETRIAL CARCINOMA. International Journal of Gynecological Cancer 32 (Suppl. 2): A159, Oct 2022. Available from: URL: http://​doi.​org/​10.​1136/​ijgc-2022-ESGO.​339 [abstract]
Metadaten
Titel
Carboplatin/paclitaxel
Lack of efficacy: case report
Publikationsdatum
01.01.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-30508-3

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Antineoplastics

Case report

Salicylic-acid

Case report

Vincristine

Case report

Crizotinib